Clinical trial · Interventional
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
NCT06360627CI-TRIAL-00075934recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Lung Embolism | — | UNRESOLVED | — |
| Pneumonia | — | UNRESOLVED | — |
| Radiation Exposure | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Computed Tomography | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Low Dose
- description
- Standard Low Dose CT
- interventionNames
- Radiation: Computed Tomography
- type
- OTHER
- label
- Ultra Low Dose
- description
- Ultra Low Dose CT
- interventionNames
- Radiation: Computed Tomography
Primary outcomes (2)
- measure
- Dose Reduction by new scanner
- timeFrame
- through study completion, an average of 1 year
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * CT SCAN for pulmonary nodule detection/follow up * CT SCAN for pneumonia detection/follow up Exclusion Criteria: * under 18 * BMI over 30
References
Publications (0)
Data not yet available
No reference posted for this study.